Quick Takeaways
- EYPT - EyePoint, Inc. has 22 insiders with reported activity on this page.
- Net insider value flow over the last year: -$1,799,057.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 22 Insiders of EyePoint, Inc.
- Symbol
- EYPT on Nasdaq
- Location
- Watertown, MA
What Changed
- Buy value: $133,174; sell value: $1,932,231.
- Net share flow: -98,641.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$1,799,057.
Buys
$133,174
Shares: 21,500
Insiders: 2
Sells
$1,932,231
Shares: 120,141
Insiders: 3
Net
-$1,799,057
Shares: -98,641
Insiders: -1
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 1,500 | 4,875 | $19,724 | $80,127 | -$60,403 |
| 3-6 | 0 | 115,266 | $0 | $1,852,104 | -$1,852,104 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 20,000 | 0 | $113,450 | $0 | +$113,450 |
EyePoint, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | Former 10% Owner | $129,793,560 | -$942,240 | -0.72% | Filing P/S | 04 Dec 2025 |
| EW Healthcare Partners, L.P. | Other*, 10%+ Owner | $87,327,483 | Mixed | 01 Sep 2023 | ||
| Nancy Lurker | Director | $7,696,047 | -$150,942 | -1.9% | Mixed | 06 Jan 2026 |
| Jay S. Duker | President and CEO, Director | $3,259,678 | +$19,724 | +0.61% | Mixed | 23 Mar 2026 |
| Therapeutics Ocumension | Director | $2,507,088 | Mixed | 11 Jan 2024 | ||
| Ye Liu | Director | $2,507,088 | Mixed | 11 Jan 2024 | ||
| George Elston | Chief Financial Officer | $1,820,288 | Mixed | 02 Mar 2026 | ||
| David Scott Jones | SVP & Chief Commercial Officer | $1,437,581 | Mixed | 09 Feb 2024 | ||
| Dario A. Paggiarino | Chief Medical Officer | $1,386,544 | Mixed | 30 Mar 2024 | ||
| Michael Craig Pine | Chief Corp Dev.&Strat. Officer | $965,391 | Mixed | 05 Jan 2024 | ||
| Ramiro Ribeiro | Chief Medical Officer | $512,120 | -$839,049 | -62% | Mixed | 04 Mar 2026 |
| Karen L. Zaderej | Director | $382,875 | +$113,450 | +42% | Mixed | 02 Jan 2026 |
| Douglas Evan Godshall | Director | $200,525 | Mixed | 22 Jun 2021 | ||
| John B. Landis | Director | $185,752 | Mixed | 02 Jan 2026 | ||
| Anthony P. Adamis | Director | $61,783 | Mixed | 23 Jun 2024 | ||
| David R. Guyer | Director | $18,619 | Filing P/S | 12 Jul 2024 | ||
| Fred Hassan | Director | Mixed | 02 Jan 2026 | |||
| Wendy F. Dicicco | Director | Mixed | 02 Jan 2026 | |||
| Stuart Duty | Director | Mixed | 02 Jan 2026 | |||
| Goran Ando | Director | Mixed | 02 Jan 2026 | |||
| Reginald J. Sanders | Director | Mixed | 02 Jan 2026 | |||
| Adage Capital Management, L.P. | 10%+ Owner | Mixed | 18 Apr 2024 |
Top shareholders of EyePoint, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP |
13F
13D/G
3/4/5
|
Company · Former 10% Owner |
10%
from 13D/G
|
8,265,000
|
$151,001,550 | — | 31 Dec 2025 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
9.5%
|
7,827,685
|
$143,011,805 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
6.5%
from 13D/G
|
6,787,872
|
$124,014,422 | — | 31 Dec 2025 | |
| FEDERATED HERMES, INC. |
13F
13D/G
|
Company |
6.7%
from 13D/G
|
6,017,433
|
$109,938,500 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
13D/G
|
Company |
6.1%
from 13D/G
|
4,976,915
|
$90,928,238 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.9%
|
4,822,139
|
$88,100,480 | — | 31 Dec 2025 | |
| EW Healthcare Partners, L.P. |
3/4/5
|
Other*, 10%+ Owner |
—
class O/S missing
|
3,490,921
|
$87,327,483 | — | 01 Sep 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
5.7%
|
4,700,000
|
$85,869,000 | — | 31 Dec 2025 | |
| Adage Capital Management, L.P. |
13D/G
3/4/5
|
10%+ Owner |
5.7%
|
4,700,000
|
$81,921,000 | -$14,986,000 | 31 Dec 2025 | |
| Paradigm Biocapital Advisors LP |
13F
13D/G
|
Company |
5.1%
from 13D/G
|
3,691,475
|
$67,443,248 | — | 31 Dec 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
4.3%
|
3,572,335
|
$65,266,560 | — | 31 Dec 2025 | |
| TCG Crossover GP II, LLC |
13D/G
|
— |
4.3%
|
3,572,335
|
$62,265,799 | $0 | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.6%
|
2,937,729
|
$53,657,620 | — | 31 Dec 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
3%
|
2,468,314
|
$45,096,097 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
1,899,367
|
$34,709,656 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
1,834,850
|
$33,522,710 | — | 31 Dec 2025 | |
| Aberdeen Group plc |
13F
|
Company |
2%
|
1,605,984
|
$29,341,328 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.5%
|
1,249,757
|
$22,833,061 | — | 31 Dec 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
— |
4.7%
|
3,181,818
|
$20,809,090 | $0 | 31 Dec 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
1.3%
|
1,088,033
|
$19,878,363 | — | 31 Dec 2025 | |
| Essex Woodlands Management, Inc. |
13F
|
Company |
1.3%
|
1,084,857
|
$19,820,336 | — | 31 Dec 2025 | |
| 5AM Venture Management, LLC |
13F
|
Company |
1.3%
|
1,050,000
|
$19,183,500 | — | 31 Dec 2025 | |
| Spruce Street Capital LP |
13F
|
Company |
1.2%
|
981,543
|
$17,932,791 | — | 31 Dec 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.95%
|
784,403
|
$14,331,043 | — | 31 Dec 2025 | |
| Patient Square Capital LP |
13F
|
Company |
0.95%
|
780,000
|
$14,250,600 | — | 31 Dec 2025 | |
| Artia Global Partners LP |
13F
|
Company |
0.93%
|
767,098
|
$14,014,880 | — | 31 Dec 2025 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
0.84%
|
690,000
|
$12,606,300 | — | 31 Dec 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.82%
|
674,395
|
$12,321,721 | — | 31 Dec 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.8%
|
661,452
|
$12,084,727 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.79%
|
648,565
|
$11,849,283 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.72%
|
595,392
|
$10,877,812 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.7%
|
577,586
|
$10,552,496 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.68%
|
556,469
|
$10,166,689 | — | 31 Dec 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.66%
|
544,077
|
$9,940,287 | — | 31 Dec 2025 | |
| Principia Wealth Advisory, LLC |
13F
|
Company |
0.65%
|
530,725
|
$9,696,346 | — | 31 Dec 2025 | |
| Nancy Lurker |
3/4/5
|
Director |
—
mixed-class rows
|
488,505
mixed-class rows
|
$7,696,047 | -$150,942 | 06 Jan 2026 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.51%
|
416,100
|
$7,602,154 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.49%
|
402,063
|
$7,343,545 | — | 31 Dec 2025 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
0.48%
|
392,594
|
$7,172,692 | — | 31 Dec 2025 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.46%
|
375,264
|
$6,856,073 | — | 31 Dec 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.45%
|
366,675
|
$6,699,152 | — | 31 Dec 2025 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.43%
|
353,849
|
$6,464,821 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.41%
|
339,004
|
$6,193,603 | — | 31 Dec 2025 | |
| Bleichroeder LP |
13F
|
Company |
0.39%
|
316,515
|
$5,782,729 | — | 31 Dec 2025 | |
| MYDA Advisors LLC |
13F
|
Company |
0.36%
|
300,000
|
$5,481,000 | — | 31 Dec 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.31%
|
258,739
|
$4,727,162 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
256,743
|
$4,690,689 | — | 31 Dec 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.3%
|
246,279
|
$4,500,000 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.28%
|
226,770
|
$4,143,088 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.27%
|
223,699
|
$4,086,982 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for EyePoint, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Jay S. Duker | EYPT | Common Stock | Other | 76.3% | 76,766 | 177,431 | 23 Mar 2026 | By Family Trust | ||
| Jay S. Duker | EYPT | Common Stock | Other | -98.7% | -76,766 | 986 | 23 Mar 2026 | Direct | ||
| Jay S. Duker | EYPT | Stock Option (Right to Buy) | Other | 150,000 | 97,500 | 23 Mar 2026 | By Family Trust | |||
| Jay S. Duker | EYPT | Stock Option (Right to Buy) | Other | -95.1% | -150,000 | 7,800 | 23 Mar 2026 | Direct | ||
| Jay S. Duker | EYPT | Common Stock | Purchase | 1.51% | $19,724 | $13.15 | 1,500 | 100,665 | 16 Mar 2026 | By Family Trust |
| Ramiro Ribeiro | EYPT | Common Stock | Sale | -100% | $43,572 | $17.87 | -2,438 | 0 | 04 Mar 2026 | Direct |
| Ramiro Ribeiro | EYPT | Common Stock | Options Exercise | 2,438 | 2,438 | 04 Mar 2026 | Direct | |||
| Ramiro Ribeiro | EYPT | Stock Option (Right to Buy) | Options Exercise | -2.86% | -2,438 | 82,875 | 04 Mar 2026 | Direct | ||
| George Elston | EYPT | Common Stock | Gift | 20% | 5,000 | 30,000 | 02 Mar 2026 | By Family Trust | ||
| George Elston | EYPT | Common Stock | Gift | -5.39% | -5,000 | 87,818 | 02 Mar 2026 | Direct | ||
| Ramiro Ribeiro | EYPT | Common Stock | Sale | -100% | $36,555 | $15.00 | -2,437 | 0 | 17 Feb 2026 | Direct |
| Ramiro Ribeiro | EYPT | Common Stock | Options Exercise | 2,437 | 2,437 | 17 Feb 2026 | Direct | |||
| Ramiro Ribeiro | EYPT | Stock Option (Right to Buy) | Options Exercise | -2.78% | -2,437 | 85,313 | 17 Feb 2026 | Direct | ||
| Nancy Lurker | EYPT | Common Stock | Options Exercise | 34.3% | 75,133 | 294,346 | 06 Jan 2026 | Direct | ||
| Nancy Lurker | EYPT | Restricted Stock Units | Options Exercise | -100% | -75,133 | 0 | 06 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Common Stock | Tax liability | -11.4% | -10,054 | 77,752 | 06 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Common Stock | Options Exercise | 31% | 20,793 | 87,806 | 06 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Restricted Stock Units | Options Exercise | -100% | -20,793 | 0 | 06 Jan 2026 | Direct | ||
| George Elston | EYPT | Common Stock | Tax liability | -4.66% | -4,487 | 91,852 | 06 Jan 2026 | Direct | ||
| George Elston | EYPT | Common Stock | Options Exercise | 18.9% | 15,285 | 96,339 | 06 Jan 2026 | Direct | ||
| George Elston | EYPT | Restricted Stock Units | Options Exercise | -100% | -15,285 | 0 | 06 Jan 2026 | Direct | ||
| Ramiro Ribeiro | EYPT | Common Stock | Sale | -100% | $727,319 | $17.10 | -42,544 | 0 | 05 Jan 2026 | Direct |
| Ramiro Ribeiro | EYPT | Common Stock | Options Exercise | 220% | 29,250 | 42,544 | 05 Jan 2026 | Direct | ||
| Ramiro Ribeiro | EYPT | Stock Option (Right to Buy) | Options Exercise | -25% | -29,250 | 87,750 | 05 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Common Stock | Tax liability | -17.8% | -14,505 | 67,013 | 05 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Common Stock | Options Exercise | 58.2% | 30,000 | 81,518 | 05 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Restricted Stock Units | Options Exercise | -50% | -30,000 | 30,000 | 05 Jan 2026 | Direct | ||
| George Elston | EYPT | Common Stock | Tax liability | -5.15% | -4,403 | 81,054 | 05 Jan 2026 | Direct | ||
| George Elston | EYPT | Common Stock | Options Exercise | 21.3% | 15,000 | 85,457 | 05 Jan 2026 | Direct | ||
| George Elston | EYPT | Restricted Stock Units | Options Exercise | -50% | -15,000 | 15,000 | 05 Jan 2026 | Direct | ||
| Nancy Lurker | EYPT | Common Stock | Options Exercise | 6.13% | 12,666 | 219,213 | 05 Jan 2026 | Direct | ||
| Nancy Lurker | EYPT | Restricted Stock Units | Options Exercise | -50% | -12,666 | 12,667 | 05 Jan 2026 | Direct | ||
| Ramiro Ribeiro | EYPT | Common Stock | Tax liability | -32.4% | -6,373 | 13,294 | 03 Jan 2026 | Direct | ||
| Ramiro Ribeiro | EYPT | Common Stock | Options Exercise | 19,667 | 19,667 | 03 Jan 2026 | Direct | |||
| Ramiro Ribeiro | EYPT | Restricted Stock Units | Options Exercise | -33.3% | -19,667 | 39,333 | 03 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Common Stock | Tax liability | -31.3% | -23,447 | 51,518 | 03 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Common Stock | Options Exercise | 652.3% | 65,000 | 74,965 | 03 Jan 2026 | Direct | ||
| Jay S. Duker | EYPT | Restricted Stock Units | Options Exercise | -33.3% | -65,000 | 130,000 | 03 Jan 2026 | Direct | ||
| George Elston | EYPT | Common Stock | Tax liability | -8.24% | -6,324 | 70,457 | 03 Jan 2026 | Direct | ||
| George Elston | EYPT | Common Stock | Options Exercise | 34.4% | 19,667 | 76,781 | 03 Jan 2026 | Direct | ||
| George Elston | EYPT | Restricted Stock Units | Options Exercise | -33.3% | -19,667 | 39,333 | 03 Jan 2026 | Direct | ||
| Ramiro Ribeiro | EYPT | Stock Option (Right to Buy) | Award | 171,400 | 171,400 | 02 Jan 2026 | Direct | |||
| Ramiro Ribeiro | EYPT | Restricted Stock Units | Award | 85,700 | 85,700 | 02 Jan 2026 | Direct | |||
| Jay S. Duker | EYPT | Stock Option (Right to Buy) | Award | 331,000 | 331,000 | 02 Jan 2026 | Direct | |||
| Jay S. Duker | EYPT | Restricted Stock Units | Award | 165,000 | 165,000 | 02 Jan 2026 | Direct | |||
| George Elston | EYPT | Stock Option (Right to Buy) | Award | 126,000 | 126,000 | 02 Jan 2026 | Direct | |||
| George Elston | EYPT | Restricted Stock Units | Award | 63,000 | 63,000 | 02 Jan 2026 | Direct | |||
| Karen L. Zaderej | EYPT | Stock Option (Right to Buy) | Award | 40,000 | 40,000 | 02 Jan 2026 | Direct | |||
| Reginald J. Sanders | EYPT | Stock Option (Right to Buy) | Award | 40,000 | 40,000 | 02 Jan 2026 | Direct | |||
| Nancy Lurker | EYPT | Stock Option (Right to Buy) | Award | 40,000 | 40,000 | 02 Jan 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.